Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE (0.85%), DAX (0.91%), CAC40 (0.33%)

Apr 16 ,2025

  • Synopsis

    • European equity markets are set for a negative open amidst mostly lower equities in Asia Wednesday. Hong Kong down sharply alongside Shenzhen and Taiwan, while Shanghai Composite tracking more moderate losses with Japan and South Korea. Australia higher after a flat open. Regional complexion softened with US futures following Nvidia (NVDA) headlines and latest tariff developments.

    • US President Trump hosting Italian PM Meloni. Polish PM Tusk holds bilateral talks with Chancellor Scholz. Portugal general election tv debates on RTP1 at 21:00CET (Nuno Melo (AD) x Mariana Mortágua (BE)) and on CNN Portugal at 22:00 (André Ventura (Chega) x Paulo Raimundo (CDU)). WTO due to release global trade forecasts.

    • Inflation data in focus on the the macro front with Italy and Eurozone Mar final CPI, UK Mar CPI/RPI and Austria Apr final CPI

    • A busy earnings front sees ASML Holding (ASML.NA) reporting Q1 EPS €6.00 vs consensus €5.74, guiding Q2 and keeping FY26 outlook unchanged. In the DACHs region, Sartorius (SRT3.GR) reported Q1 EPS €1.22 vs FactSet €1.18 and guides FY underlying EBITDA margin of ~29 to 30%. In France, Sartorius Stedim Biotech (DIM.FP) reported Q1 EPS €1.16 ex-items vs FactSet €0.94 whilst VINCI (DG.FP) is out with Mar airport passenger traffic +4.9%. Ipsen (IPN.FP) is out with Q1 revenue €918.8M vs StreetAccount €906.3M and Edenred (EDEN.FP) reported Q1 Operating revenue €667M vs StreetAccount €664.3M and confirmed 2025 guidance.

  • Politics/Macro/World News

    • Markets focus on lack of progress in US trade talks

  • Top company news

    • Earnings/updates

      • Benelux:

        • ASML.NA (ASML Holding) -- reports Q1 EPS €6.00 vs consensus €5.74; guides Q2 and keeps FY26 outlook unchanged

        • BAR.BB (Barco) -- reports Q1 revenue €211.6M vs FactSet €210.2M [2 est, €208.4-212M]

      • France:

        • DIM.FP (Sartorius Stedim Biotech) -- reports Q1 EPS €1.16 ex-items vs FactSet €0.94 [5 est, €0.76-1.07]

        • DG.FP (VINCI SA) -- Vinci reports Mar airport passenger traffic +4.9%

        • IPN.FP (Ipsen) -- reports Q1 revenue €918.8M vs StreetAccount €906.3M; reaffirms FY guidamce

        • EDEN.FP (Edenred) -- reports Q1 Operating revenue €667M vs StreetAccount €664.3M; confirms 2025 guidance

        • FDJU.FP (La Francaise des Jeux) -- reports Q1 revenue €925M, +30% vs year-ago reported €710M

        • VIRP.FP (Virbac) -- reports Q1 revenue €375.2M, +9% vs year-ago €345.7M

      • DACH:

        • SRT3.GR (Sartorius) -- reports Q1 EPS €1.22 vs FactSet €1.18 [9 est, €1.04-1.30]; guides FY underlying EBITDA margin of ~29 to 30%

        • HLE.GR (FORVIA HELLA) -- reports Q1 revenue €2.00B vs FactSet €1.96B [1 est]

        • ADV.GR (Adtran Networks) -- reports preliminary FY24 IFRS pro forma EBIT (€10.2M) vs prior guidance (€4.5M)

        • GURN.SW (Gurit Holding) -- reports Q1 revenue CHF85.2M vs FactSet CHF86.7M [1 est]

        • IDIA.SW (Idorsia) -- announces higher cantonal composition authority approved amendments to terms of 2025 convertible bond

        • FLU.AV (Flughafen Wien) -- reports Mar group total passenger traffic +4.1% to 2.99M

        • MARI.AV (Marinomed Biotech) -- reports FY net income (€15.4M) vs preliminary ~(CHF15M) and FactSet (€15.1M) [1 est]

      • Nordics:

        • EQT.SS (EQT) -- reports Q1 FAUM €142B vs year-ago €132B

        • UPM.FH (UPM-Kymmene) -- provides update on labor dispute; strikes continue

        • NDA.SE.SS (Nordea Bank) -- reports Q1 EPS €0.35 vs FactSet €0.32 [16 est, €0.29-0.35]

        • BWLPG.NO (BW LPG) -- reports Q1 product services net result ~($12M)

        • BMAX.SS (Byggmax Group) -- reports Q1 EPS (SEK1.90) vs FactSet (SEK2.07) [2 est, (SEK2.20)-(1.94)]

      • Southern Europe:

        • OVS.IM (OVS) -- reports FY adjusted net income €77.9M vs FactSet €82.8M

      • UK:

        • RIO.LN (Rio Tinto) -- reports Q1 Pilbara iron ore production (100% basis) 69.8Mt vs StreetAccount 74.0M

    • M&A

      • BLV.FP (Believe) -- 's majority shareholder, Upbeat BidCo, announces its intention to file a public buy-out offer for the company, followed by a squeeze-out on the shares it does not hold

      • BARC.LN (Barclays) -- reportedly close to reaching agreement on sale of stake in payments business to Brookfield (BAM) -- Bloomberg

      • D6H.GR (Datagroup) -- KKR launches takeover offer for Datagroup at €54/sh cash

      • MB.IM (Mediobanca) -- Banco BPM, Anima set to support Monte dei Paschi's bid for Mediobanca at investor meeting - Bloomberg

    • Healthcare

      • BSLN.SW (Basilea Pharmaceutica) -- announces presentation of new data for fosmanogepix, isavuconazole (Cresemba) and ceftobiprole (Zevtera) at ESCMID Global 2025

      • BIOA.B.SS (BioArctic) -- AB's partner Eisai granted application for Marketing Authorization of Leqembi (lecanemab) for treatment of early Alzheimer's disease in the EU

    • Other

      • MELE.BB (Melexis) -- to establish a locally embedded logistics hub and end-to-end local manufacturing in China

      • AGAS.NO (Avance Gas Holding) -- declares final extraordinary distribution of $0.74/share

      • TTE.FP (TotalEnergies) -- maintains commitment to increase oil, gas and clean energy businesses - FT

      • LDO.IM (Leonardo) -- Leonardo's AgustaWestland named principal contractor for $120M sale to Government of Philippines

      • EPI.A.SS (Epiroc) -- awarded A$350M (SEK2.2B) contract to deliver fully-autonomous and electric surface mining equipment to Fortescue

      • PTEC.LN (Playtech) -- set to name John Gleason as its next chair -- Sky News

      • WDP.BB (Warehouses de Pauw) -- announces real estate deal with Kris De Leeneer (KDL)

      • BHP partners with Acciona Energía to explore development of pumped hydro energy storage project at Mt Arthur Coal

      • Rio Tinto shares trading (1.9%) lower post mixed Q1 production result; iron ore volumes missed expectations due to cyclone disruptions

  • Key rating changes

    • Upgrades

      • BNP Paribas Exane upgrades AED.BB, BYG.LN, GPE.LN, and HMSO.LN; downgrades COL.SM; resumes TEG.GR

      • BOWL.LN (Hollywood Bowl Group) -- to buy from add at Peel Hunt

    • Downgrades

      • VIE.FP (Veolia Environnement) -- underperform from hold at Jefferies

      • MC.FP (LVMH Moet Hennessy Louis Vuitton) -- to hold from buy at TD Cowen

    • Initiations

      • AZN.LN (AstraZeneca) -- outperform at BNP Paribas Exane

      • GSK.LN (GSK Plc) -- neutral at BNP Paribas Exane

      • IPN.FP (Ipsen) -- neutral at BNP Paribas Exane

      • GALD.SW (Galderma Group) -- outperform at BNP Paribas Exane

      • NDX1.GR (Nordex) -- buy at Berenberg

  • Data

    • Nikkei (1.57%) to 33729.74

    • Hang Seng (2.65%) to 20897.22

    • Shanghai Composite (0.74%) to 3243.52

    • S&P futures (80.3) vs prior close of 5428.3

    • €-$ +0.0100 or +0.89% to 1.1383

    • $-¥ (1.12) or (0.78%) to 142.13

    • €-¥ +0.09 or +0.06% to 161.70

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE